| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 3 |
| 1 | BUSULFAN | 2 |
| 2 | ETOPOSIDE | 2 |
| 3 | IFOSFAMIDE | 2 |
| 4 | IFOSFAMIDE FOR INJECTION | 2 |
| 5 | MITOXANTRONE HYDROCHLORIDE | 2 |
| 6 | CYCLOPHOSPHAMIDE | 1 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 1 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 1 |
| 9 | DICLOFENAC | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRABECTEDIN | 1 | 0.0004 |
| 1 | MITOXANTRONE HYDROCHLORIDE | 2 | 0.0003 |
| 2 | BUSULFAN | 2 | 0.0001 |
| 3 | IFOSFAMIDE FOR INJECTION | 2 | 0.0001 |
| 4 | ETOPOSIDE | 2 | 0.0000 |
| 5 | RITUXIMAB | 3 | 0.0000 |
| 6 | DOXORUBICIN | 1 | 0.0000 |
| 7 | DICLOFENAC SODIUM | 1 | 0.0000 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 1 | 0.0000 |
| 9 | CYCLOPHOSPHAMIDE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 4 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 3 |
| 2 | Topoisomerase Inhibitor [EPC] | 2 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 |
| 4 | Proton Pump Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 1 | Alkylating Drug [EPC] | 4 | 0.0000 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 3 | 0.0000 |
| 3 | Proton Pump Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |